Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line

Oncology Reports

Volumn 8, Issue 4, 2001, Pages 825-829

  Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Caspase; Lung cancer; Nf b; Paclitaxel; Proteasome inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CYSTEINE PROTEINASE; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MULTIENZYME COMPLEX; PACLITAXEL; PROTEASOME;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYMOLOGY; FLOW CYTOMETRY; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL CYCLE; CYSTEINE ENDOPEPTIDASES; DRUG SYNERGISM; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MULTIENZYME COMPLEXES; NF-KAPPA B; PACLITAXEL; PROTEASOME ENDOPEPTIDASE COMPLEX; TUMOR CELLS, CULTURED;

EID: 0035408344     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Wani MC, Taylor HL, Wall ME, Coggen P and McPhail AT: Plant antitumor agents. VI. The isolation and structure of taxol, a novel aritilcukemic and antitumor asent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1990.